The Zacks Analyst Blog Highlights: UnitedHealth Group, Aetna, WellPoint, Humana and Greenway Medical Technologies

Mon Oct 21, 2013 9:30am EDT

* Reuters is not responsible for the content in this press release.

The Zacks Analyst Blog Highlights: UnitedHealth Group, Aetna, WellPoint, Humana and Greenway Medical Technologies

PR Newswire

CHICAGO, Oct. 21, 2013 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the UnitedHealth Group Inc. (NYSE:UNH-Free Report), Aetna Inc. (NYSE:AET-Free Report), WellPoint Inc. (NYSE:WLP-Free Report), Humana Inc. (NYSE:HUM-Free Report) and Greenway Medical Technologies Inc. (NYSE:GWAY-Free Report).

(Logo: http://photos.prnewswire.com/prnh/20101027/ZIRLOGO)

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.

Here are highlights from Friday's Analyst Blog:

The Obamacare Effect: 3 Great Insurance Stocks

With the sixteen day partial government shutdown coming to an end, critics of Obamacare have shifted their focus from aspects of the laws which they find objectionable. Now, the various problems occurring its implementation have become the focal point of their discussions.

Rollout Glitches

Even as the government shutdown began, Obamacare had already come into effect. Online insurance exchanges are at the heart of the new regime and have been operative since October 1. But they have been plagued by serious problems and remain unusually difficult to use.

Healthcare.gov, the portal for insurance registration in 36 states, has been affected by a series of technical problems. These include delays in loading pages, error messages and undecipherable text. The Obama administration has said that this is primarily due to the large number of visitors during the first 10 days, a figure which it says is in excess of 14.6 million.

Health and Human Services Secretary Kathleen Sebelius has acknowledged that the rollout has faced serious problems. However, speaking to an audience at Cincinnati she said "constant improvements are underway, so that we are getting people in much more quickly."

The Insurance Sector Impact

The reason why investors and insurers alike continue to be wary of the Obamacare launch is not just the fees and restrictions it requires of insurers. The Act reduces funding for Medicare Advantage, which benefits the elderly and disabled. This could result in lower profit margins for investors.

One among the larger insurers, UnitedHealth Group Inc. (NYSE:UNH-Free Report) reported its earnings this week, which were near enough estimates to be satisfactory. Third quarter earnings for 2013 came in at $1.53 per share, missing the Zacks Consensus Estimate by a penny. Earnings continued to grow at 2.0% year over year. This was primarily due to increased enrollment and higher revenues.

Among other major players, Aetna Inc. (NYSE:AET-Free Report) and WellPoint Inc. (NYSE:WLP-Free Report) are slated to report earnings later in October while Humana Inc. (NYSE:HUM-Free Report) will release these numbers in November. The response to the new situation from most of the major players in the sector has been to refrain from participating in state-run exchanges. For instance, in Connecticut, the number of insurers is now down to three.    

Initial numbers have shown that the number of customers signing up will increase. There are also indications of a rise in premiums. Eventually, much will depend on the success of Obamacare but the decision to selectively choose state exchanges is meant to counter a situation in which the number of users signing up remains low.  

3 Great Choices

If Aetna and Humana continue the trend set by UnitedHealth, they may become the best choices from the insurance sector. These three are also essential additions when it comes to investing in the healthcare sector.

UnitedHealth

As discussed earlier, UnitedHealth has not disappointed investors hugely with its earnings numbers. In fact, it has increased the lower bound of its earlier 2013 EPS forecast. It now expects earnings per share of $5.40 to $5.50. The company continues to state that its 2013 revenue expectation is $122 billion.

UnitedHealth holds a Zacks Rank #2(Buy) and has expected earnings growth of 9.85%. The forward price-to-earnings Ratios (P/E) for the current financial year (F1) is 13.03.

Aetna

Next up we have Aetna. The company has recently formed an Accountable Care Organization with WellSpan Health. This is in keeping with the company's efforts to improve safety and quality of patient care and reduce the costs of healthcare.

Aetna has also acquired Coventry this year, which has resulted in multiple benefits for the company. Currently the company holds a Zacks Rank #2(Buy) and has expected earnings growth of 11.94%. It has a P/E (F1) of 10.90.

Humana

Our third choice is Humana. Recently, it has entered into a partnership with prominent home health service provider Valued Relationships Inc. The association with Valued Relationships will reduce the serious long term effects of medical emergencies faced by customers.

The company has also entered into strategic alliances with the likes of Boehringer Ingelheim Pharmaceuticals, and Greenway Medical Technologies Inc. (NYSE:GWAY-Free Report) Besides a Zacks Rank #2 (Buy), the company has expected earnings growth of 10.56%. It has a P/E (F1) of 10.65.

Though the introduction of Obamacare has radically changed the healthcare insurance environment these three choices are large companies with the ability to tide over such choices. All of these three choices would make good additions to your portfolio.

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today.

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978. The later formation of the Zacks Rank, a proprietary stock picking system; continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros.  In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros.

Get the full Report on UNH - FREE

Get the full Report on AET - FREE

Get the full Report on WLP - FREE

Get the full Report on HUM - FREE

Get the full Report on GWAY - FREE

Follow us on Twitter: http://twitter.com/zacksresearch

Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact
Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

http://www.zacks.com

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.

SOURCE Zacks Investment Research, Inc.

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.